Showing results (131-140 of 216) with videos related to
Sort By:
Pageof 22
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2013
123I-iodobenzamide SPECT is not an independent predictor of dopaminergic responsiveness in patients with suspected atypical parkinsonian syndromesSabine Hellwig, Annabelle Kreft, Florian Amtage, et al.Medical Physics|September 19, 2025
Single-time-point tumor dosimetry using population-based model selection and nonlinear mixed-effects modeling in [<sup>177</sup>Lu]Lu-PSMA-617 therapyDeni Hardiansyah, Elham Yousefzadeh-Nowshahr, Indra Budiansah, et al.Neuroradiology|May 24, 2025
Measuring cerebrovascular reactivity with breath-hold fMRI in patients with Moyamoya angiopathy: MR perfusion based delay correction significantly improves agreement to [<sup>15</sup>O]water PETLeonie Zerweck, Uwe Klose, Constantin Roder, et al.Nuklearmedizin. Nuclear Medicine|April 9, 2024
FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL)Christoph-Ferdinand Wielenberg, Johannes Christian Fostitsch, Christian Volz, et al.Anatomy and Embryology|September 28, 2005
Analysis of neuroreceptor PET-data based on cytoarchitectonic maximum probability maps: a feasibility studyRené Hurlemann, Andreas Matusch, Simon B Eickhoff, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2018
Performance of <sup>111</sup>In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomyMichael Mix, Kathrin Reichel, Christian Stoykow, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2018
<sup>68</sup>Ga-PSMA-HBED-CC Uptake in Cervical, Celiac, and Sacral Ganglia as an Important Pitfall in Prostate Cancer PET ImagingChristoph Rischpler, Teresa I Beck, Shozo Okamoto, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 2012
Assessment of striatal dopamine D2/D3 receptor availability with PET and 18F-desmethoxyfallypride: comparison of imaging protocols suited for clinical routineFlorian Amtage, Timo S Spehl, Sabine Hellwig, et al.Medical Physics|December 25, 2025
Accuracy and precision of few-time-points renal dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 therapy: Analysis with nonlinear mixed-effects modelingAssyifa R Hakim, Deni Hardiansyah, Elham Yousefzadeh-Nowshahr, et al.Cancer Research|February 24, 2021
Cytoplasmic Localization of Prostate-Specific Membrane Antigen Inhibitors May Confer Advantages for Targeted Cancer TherapiesJessica Matthias, Johann Engelhardt, Martin Schäfer, et al.Pageof 22